216 related articles for article (PubMed ID: 11228496)
1. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia.
Zhong XY; Laivuori H; Livingston JC; Ylikorkala O; Sibai BM; Holzgreve W; Hahn S
Am J Obstet Gynecol; 2001 Feb; 184(3):414-9. PubMed ID: 11228496
[TBL] [Abstract][Full Text] [Related]
2. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha levels.
Livingston JC; Park V; Barton JR; Elfering S; Haddad B; Mabie WC; Quasney M; Sibai BM
Am J Obstet Gynecol; 2001 May; 184(6):1273-7. PubMed ID: 11349201
[TBL] [Abstract][Full Text] [Related]
3. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction.
Alberry MS; Maddocks DG; Hadi MA; Metawi H; Hunt LP; Abdel-Fattah SA; Avent ND; Soothill PW
Am J Obstet Gynecol; 2009 Jan; 200(1):98.e1-6. PubMed ID: 19121662
[TBL] [Abstract][Full Text] [Related]
4. [Study on the relation between concentration of circulating non-host fetal DNA in pregnant women and pre-eclampsia].
Tao H; Wang XM; Ji XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):808-11. PubMed ID: 16412324
[TBL] [Abstract][Full Text] [Related]
5. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
[TBL] [Abstract][Full Text] [Related]
6. [Quantity of total cell free and cell free fetal DNA in pregnancies with no complications and with preeclampsia].
Lázár L; Nagy B; Molvarec A; Rigó J
Orv Hetil; 2010 May; 151(19):784-7. PubMed ID: 20427261
[TBL] [Abstract][Full Text] [Related]
7. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia.
Livingston JC; Barton JR; Park V; Haddad B; Phillips O; Sibai BM
Am J Obstet Gynecol; 2001 Jul; 185(1):153-7. PubMed ID: 11483920
[TBL] [Abstract][Full Text] [Related]
8. Maternal EDN1 G5665T polymorphism influences circulating endothelin-1 levels and plays a role in determination of preeclampsia phenotype.
Aggarwal PK; Jain V; Srinivasan R; Jha V
J Hypertens; 2009 Oct; 27(10):2044-50. PubMed ID: 19730395
[TBL] [Abstract][Full Text] [Related]
9. The analysis of the correlation between extracellular fetal DNA concentration in maternal circulation and severity of preeclampsia.
Engel K; Płonka T; Bilar M; Czajkowska E; Orzińska E; Brojer E; Ronin-Walknowska E
Ann Acad Med Stetin; 2007; 53(3):20-5. PubMed ID: 18595481
[TBL] [Abstract][Full Text] [Related]
10. Decreased maternal serum leptin in pregnancies complicated by preeclampsia.
Laml T; Preyer O; Hartmann BW; Ruecklinger E; Soeregi G; Wagenbichler P
J Soc Gynecol Investig; 2001; 8(2):89-93. PubMed ID: 11336879
[TBL] [Abstract][Full Text] [Related]
11. Significant correlation between maternal body mass index at delivery and in the second trimester, and second trimester circulating total cell-free DNA levels.
Lapaire O; Volgmann T; Grill S; Hösli I; Zanetti-Daellenbach R; Zhong XY; Holzgreve W
Reprod Sci; 2009 Mar; 16(3):274-9. PubMed ID: 19087977
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome.
Shaarawy M; El Meleigy M; Rasheed K
J Soc Gynecol Investig; 2001; 8(1):27-31. PubMed ID: 11223354
[TBL] [Abstract][Full Text] [Related]
13. Circulating calcitonin gene-related peptide and its placental origins in normotensive and preeclamptic pregnancies.
Dong YL; Chauhan M; Green KE; Vegiraju S; Wang HQ; Hankins GD; Yallampalli C
Am J Obstet Gynecol; 2006 Dec; 195(6):1657-67. PubMed ID: 16996466
[TBL] [Abstract][Full Text] [Related]
14. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients.
Farina A; Sekizawa A; Sugito Y; Iwasaki M; Jimbo M; Saito H; Okai T
Prenat Diagn; 2004 Feb; 24(2):83-6. PubMed ID: 14974111
[TBL] [Abstract][Full Text] [Related]
15. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia.
Cotter AM; Martin CM; O'leary JJ; Daly SF
Am J Obstet Gynecol; 2004 Aug; 191(2):515-20. PubMed ID: 15343229
[TBL] [Abstract][Full Text] [Related]
16. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction.
Illanes S; Parra M; Serra R; Pino K; Figueroa-Diesel H; Romero C; Arraztoa JA; Michea L; Soothill PW
Prenat Diagn; 2009 Dec; 29(12):1118-22. PubMed ID: 19816882
[TBL] [Abstract][Full Text] [Related]
17. Elevated circulating concentrations of platelet activating factor in preeclampsia.
Rowland BL; Vermillion ST; Roudebush WE
Am J Obstet Gynecol; 2000 Oct; 183(4):930-2. PubMed ID: 11035340
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
[TBL] [Abstract][Full Text] [Related]
19. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia.
Zhong XY; Holzgreve W; Hahn S
Hypertens Pregnancy; 2002; 21(1):77-83. PubMed ID: 12044339
[TBL] [Abstract][Full Text] [Related]
20. Maternal urine for prenatal diagnosis--an analysis of cell-free fetal DNA in maternal urine and plasma in the third trimester.
Majer S; Bauer M; Magnet E; Strele A; Giegerl E; Eder M; Lang U; Pertl B
Prenat Diagn; 2007 Dec; 27(13):1219-23. PubMed ID: 17968856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
